LifeVantage (NASDAQ:LFVN) Releases FY 2025 Earnings Guidance

LifeVantage (NASDAQ:LFVN) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided EPS guidance of 0.700-0.800 for the period, compared to the consensus EPS estimate of 0.720. The company issued revenue guidance of $200.0 million-$210.0 million, compared to the consensus revenue estimate of $204.8 million.

LifeVantage Trading Down 3.8 %

Shares of NASDAQ LFVN traded down $0.51 during midday trading on Tuesday, reaching $12.98. The company had a trading volume of 172,827 shares, compared to its average volume of 59,519. LifeVantage has a 1 year low of $4.20 and a 1 year high of $14.71. The business’s 50-day simple moving average is $10.68 and its 200 day simple moving average is $8.27. The stock has a market cap of $164.86 million, a P/E ratio of 46.14 and a beta of 0.84.

LifeVantage (NASDAQ:LFVN) last announced its quarterly earnings data on Wednesday, August 28th. The company reported $0.14 earnings per share for the quarter, missing analysts’ consensus estimates of $0.21 by ($0.07). The firm had revenue of $48.93 million during the quarter. LifeVantage had a net margin of 1.47% and a return on equity of 27.85%.

LifeVantage Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 17th. Stockholders of record on Monday, September 9th were issued a $0.04 dividend. The ex-dividend date of this dividend was Monday, September 9th. This represents a $0.16 annualized dividend and a dividend yield of 1.23%. LifeVantage’s dividend payout ratio (DPR) is presently 57.14%.

About LifeVantage

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.